The coagulase-negative staphylococci and, in particular, Staphylococcus epi
dermidis, have emerged as major nosocomial pathogens associated with infect
ions of implanted medical devices. These organisms, which are among the mos
t prevalent bacteria of the human skin and mucous membrane microflora, pres
ent unique problems in the diagnosis and treatment of infections involving
biofilm formation on implanted biomaterials. Epidemiological data that addr
ess whether invasive S. epidermidis strains can be traced to commensal orga
nisms or an endemic occurrence of distinct strains with enhanced virulence
have important implications for the implementation of appropriate infection
control measures. An extracellular polysaccharide adhesin represents a key
virulence determinant in S. epidermidis and is required for biofilm format
ion, Production of this adhesin, which is encoded by the ica operon, is sub
ject to phase variable regulation (ON <----> OFF switching). Recent advance
s in understanding the molecular events controlling polysaccharide adhesin
synthesis and the potential clinical implications of its phase variable reg
ulation are outlined. Further research in this area may contribute to the d
evelopment of novel strategies for therapeutic intervention. Finally, in ad
dition to antibiotic prophylaxis, preventive strategies to control S, epide
rmidis medical device-related infections are focusing on the development of
improved biomaterials and physical electrical barriers to impede bacterial
colonisation.